Contact Information
Pengbo Zhou, Ph.D.
Professor of Pathology and Laboratory Medicine
Weill Cornell Medical College
Selective degradation of specific cellular proteins by the ubiquitin-proteasome pathway (UPP) is essential for a variety of vital cellular functions. We are interested in aspects of the UPP pertaining to physiological and pathological conditions, including the onset and maintenance of tumor growth as well as drug susceptibility.
PI: Pengbo Zhou, Ph.D.
National Institutes of Health (NIH) Research Grant
PI: Pengbo Zhou, Ph.D.
Cullinogen, Inc Sponsored Research Agreement
PI: Pengbo Zhou, Ph.D.
The Daedalus Fund For Innovation Research Grant
PI: Pengbo Zhou, Ph.D.
Sanofi-Aventis
PI: Pengbo Zhou, Ph.D.
National Institutes of Health (NIH)
PI: Pengbo Zhou, Ph.D.
National Institutes of Health (NIH)
PI: Pengbo Zhou, Ph.D.
Clinical & Translational Science Center (CTSC)
PI: Pengbo Zhou, PhD
Co-PI: Xiaojing Ma
National Institutes of Health (R01 grant)
PI: Massimo Loda, MD
PI Pilot Award: Pengbo Zhou, PhD
National Institutes of Health/WCM (SPORE DRP Pilot grant)
PI: Pengbo Zhou, PhD
WCM Clinical and Translational Science Center
Pengbo Zhou, Ph.D.
Professor of Pathology and Laboratory Medicine
Weill Cornell Medical College